Company Number: 12946148

Analysis Date: 2025-07-20 16:18 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   ICEDENT LIMITED shows positive net assets and shareholders' funds for the latest financial year ending October 2023, reversing a prior period of negative equity. However, working capital remains tight with current assets (£18,307) falling below current liabilities (£24,701), resulting in a small negative net current assets position (-£6,394). This indicates some liquidity pressure which may constrain the company’s ability to meet short-term obligations without additional cash inflows or financing. The company’s small size (micro-entity) and limited turnover data restrict comprehensive assessment, but the improvement in net assets is a positive sign. Given the dental practice nature (SIC 86230), consistent patient flow and billing are critical. Approval is recommended with conditions including monitoring liquidity closely and requiring updated management accounts quarterly.

2. Financial Strength:
   Balance sheet strength has improved markedly from prior years which showed significant negative equity and current liabilities exceeding current assets by a wide margin (e.g., 2022 net liabilities of -£68,398). The 2023 accounts report positive net assets of £26,182, backed by fixed assets of £32,576, likely representing dental equipment or premises improvements. Share capital remains nominal at £100, which places reliance on retained earnings or external financing for capital needs. The increase in fixed assets and positive equity suggest some reinvestment and financial stabilization. However, the company remains small and vulnerable to cash flow volatility.

3. Cash Flow Assessment:
   Current liabilities exceed current assets, resulting in negative net current assets of £6,394 in 2023, a significant improvement over the prior years but still a concern. This suggests potential liquidity constraints and reliance on timely collections or short-term financing to meet immediate obligations. The average number of employees has increased slightly to 4, indicating some growth in operational costs. Without detailed cash flow statements, it is difficult to fully assess operating cash generation, but working capital management is a key risk area. The company should maintain tight controls on receivables and payables and possibly negotiate better credit terms with suppliers.

4. Monitoring Points:

• Quarterly review of cash flow forecasts and management accounts to detect liquidity issues early.
• Monitoring of current ratio and net working capital trends to ensure continued improvement.
• Watch for any delays in statutory filings or board changes that may indicate operational stress.
• Assessment of patient volume and revenue trends to confirm stable or growing income streams.
• Review of director’s conduct and credit exposure given the small shareholder base and director dependency.